BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 25835067)

  • 1. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilizing ability of surfactant on physicochemical properties of drug nanoparticles generated from solid dispersions.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1082-1092. PubMed ID: 28161991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
    Sethia S; Squillante E
    Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
    J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
    Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
    Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To evaluate the effect of addition of an anionic surfactant on solid dispersion using model drug indomethacin.
    Dave RH; Patel AD; Donahue E; Patel HH
    Drug Dev Ind Pharm; 2012 Aug; 38(8):930-9. PubMed ID: 22085470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
    Patel RP; Patel MM
    Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole.
    Dave RH; Patel HH; Donahue E; Patel AD
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1562-72. PubMed ID: 23030270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001).
    Moes JJ; Koolen SL; Huitema AD; Schellens JH; Beijnen JH; Nuijen B
    Int J Pharm; 2011 Nov; 420(2):244-50. PubMed ID: 21907780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
    Thenmozhi K; Yoo YJ
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro dissolution and physicochemical characterizations of novel PVP-based solid dispersions containing valsartan prepared by a freeze-drying method.
    Xu WJ; Liu Y; Shi LL; Cui JH; Cao QR
    Pak J Pharm Sci; 2014 Nov; 27(6):1799-804. PubMed ID: 25362604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.
    Wu K; Li J; Wang W; Winstead DA
    J Pharm Sci; 2009 Jul; 98(7):2422-31. PubMed ID: 18972575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
    Moes J; Koolen S; Huitema A; Schellens J; Beijnen J; Nuijen B
    Eur J Pharm Biopharm; 2013 Jan; 83(1):87-94. PubMed ID: 23085332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and physicochemical characterization of binary and ternary ground mixtures of carvedilol with PVP and SLS aimed to improve the drug dissolution.
    Bolourchian N; Talamkhani Z; Nokhodchi A
    Pharm Dev Technol; 2019 Nov; 24(9):1115-1124. PubMed ID: 31282827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.
    Kim MS; Kim JS; Park HJ; Cho WK; Cha KH; Hwang SJ
    Int J Nanomedicine; 2011; 6():2997-3009. PubMed ID: 22162657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.